Prophylaxis of the occurrence of hyperbilirubinemia in relation to maternal oxytocin infusion with steroid treatment

被引:6
作者
Leylek, OA [1 ]
Ergur, A
Senocak, F
Sencan, M
Bakir, S
Ozdemir, H
Songur, S
机构
[1] Sutcu Imam Univ, Fac Med, Dept Gynecol & Obstet, TR-46050 Kahramanmaras, Turkey
[2] Sutcu Imam Univ, Dept Pediat, TR-46050 Kahramanmaras, Turkey
[3] Sutcu Imam Univ, Dept Hematol, TR-46050 Kahramanmaras, Turkey
[4] Sutcu Imam Univ, Dept Biochem, TR-46050 Kahramanmaras, Turkey
关键词
oxytocin; hemolysis; hyperbilirubinemia; steroid; membrane stabilization;
D O I
10.1159/000010025
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study was carried out to investigate the steroid prevention on the occurrence and the severity of red blood cell destruction by the effect of oxytocin usage for labor induction. Venous cord blood was collected from the pregnancies who had oxytocin-induced or augmented labors (20), oxytocin-infused deliveries with steroid use (20), deliveries without oxytocin use (20) and cesarean sections (20). Evaluation of the data showed significant increase in serum bilirubin level: serum lactic dehydrogenase activity, erythrocyte fragility and reticulocyte count (p < 0.0083), and a significant decrease in hemoglobulin concentration, packed red cell volume fraction (p < 0.01) in groups with labor induction or augmentation with oxytocin in comoparison to deliveries with oxytocin plus steroid use and the two other methods of delivery. Moreover, with regard to the above data, no significant difference was observed between the deliveries other than oxytocin-only use. Mean corpuscular volume in the oxytocin group was apparently (not significant) higher than the steroid group. The results of this study suggest that the use of 16 mg dexamethasone 21-phosphate at the beginning of the induction or augmentation of labor with oxytocin, followed by an additional 4-mg dose 4 h later intravenously, is advantageous for the prevention of erythrocyte destruction.
引用
收藏
页码:164 / 168
页数:5
相关论文
共 31 条
[1]  
ALTURA BM, 1977, FED PROC, V36, P1853
[2]   DEVELOPMENT OF A RADIOIMMUNOASSAY FOR MEASUREMENT OF HUMAN-PLASMA ARGININE VASOPRESSIN [J].
BAYLIS, PH ;
HEATH, DA .
CLINICAL ENDOCRINOLOGY, 1977, 7 (02) :91-102
[3]   NEONATAL HYPERBILIRUBINEMIA FOLLOWING USE OF OXYTOCIN IN LABOR [J].
BEAZLEY, JM ;
ALDERMAN, B .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1975, 82 (04) :265-271
[4]   PATHOGENESIS OF NEONATAL HYPERBILIRUBINEMIA AFTER INDUCTION OF LABOR WITH OXYTOCIN [J].
BUCHAN, PC .
BRITISH MEDICAL JOURNAL, 1979, 2 (6200) :1255-1257
[5]  
BUCKALEW VM, 1984, ANNU REV PHYSIOL, V46, P343
[6]  
DAVIS GH, 1984, J AM OSTEOPATH ASSOC, V84, P365
[7]  
DESOUSA RC, 1978, J MEMBRANE BIOL, V20, P77
[8]   VASOPRESSIN AND OXYTOCIN IN HEALTH AND DISEASE [J].
EDWARDS, CRW .
CLINICS IN ENDOCRINOLOGY AND METABOLISM, 1977, 6 (01) :223-259
[9]  
FEY K, 1977, CIRCULATION, V56, P143
[10]  
Fey K H, 1978, Chir Forum Exp Klin Forsch, P103